| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 127.943 | 118.037 | 122.496 | 134.224 | 138.747 | 157.456 | 159.541 | 179.313 | 196.055 | 215.588 |
| Total Income - EUR | 133.812 | 121.019 | 124.064 | 135.741 | 140.807 | 160.136 | 160.764 | 184.076 | 203.869 | 221.834 |
| Total Expenses - EUR | 130.998 | 120.486 | 118.340 | 127.519 | 135.983 | 141.639 | 144.599 | 161.948 | 177.998 | 192.365 |
| Gross Profit/Loss - EUR | 2.814 | 534 | 5.724 | 8.222 | 4.824 | 18.498 | 16.165 | 22.128 | 25.871 | 29.469 |
| Net Profit/Loss - EUR | 2.364 | 448 | 4.454 | 6.865 | 3.417 | 16.938 | 14.590 | 20.324 | 23.880 | 24.012 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Eritrofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.619 | 15.460 | 15.198 | 14.919 | 10.034 | 9.844 | 9.626 | 9.655 | 9.626 | 9.572 |
| Current Assets | 55.546 | 44.200 | 46.613 | 54.910 | 54.686 | 61.758 | 65.358 | 61.590 | 77.763 | 86.803 |
| Inventories | 30.223 | 28.937 | 25.767 | 29.609 | 29.590 | 32.135 | 29.094 | 30.173 | 34.516 | 37.701 |
| Receivables | 10.501 | 4.862 | 13.464 | 17.718 | 14.896 | 21.347 | 20.708 | 20.908 | 21.390 | 18.562 |
| Cash | 14.822 | 10.401 | 7.383 | 7.582 | 10.199 | 8.276 | 15.557 | 10.509 | 21.857 | 30.539 |
| Shareholders Funds | 12.703 | 13.022 | 17.256 | 23.804 | 13.102 | 29.791 | 23.880 | 29.644 | 33.171 | 33.251 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 58.462 | 46.638 | 44.556 | 46.025 | 51.618 | 41.811 | 51.103 | 41.602 | 54.219 | 63.124 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Eritrofarm S.r.l.